Thermo Fisher’s (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY Posted byZacks Equity Research September 16, 2021 Leave a comment on Thermo Fisher’s (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY Thermo Fisher (TMO) gains FDA pre-market approval for Oncomine Dx as companion diagnostic for Takeda’s EXKIVITY.